Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases. [electronic resource]
Producer: 20200804Description: 2399-2410 p. digitalISSN:- 1432-1335
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Camptothecin -- analogs & derivatives
- Cetuximab -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Female
- Fluorouracil -- therapeutic use
- Humans
- Leucovorin -- therapeutic use
- Liver -- drug effects
- Liver Neoplasms -- pathology
- Lung Neoplasms -- pathology
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.